By Administrator at 12 May 2017

A new technique developed by researchers at the University of Missouri could prove invaluable in detecting and diagnosing melanomas, including those that have spread, or metastasized.

By Admin at 1 Jun 2016

In 2014, the FDA approved the immunotherapy drug pembrolizumab (brand name Keytruda®) for people with melanoma that cannot be removed by surgery or that has spread to other parts of the body. The drug was approved under an accelerated fast-track process because of positive initial results from a clinical trial. The end results of that study have now been released and confirm the drug’s promise for late-stage melanoma patients.

By Admin at 4 Jan 2016

Why a formerly benign mole changes into cancer has remained much of a mystery. Also up for debate was whether or not an “intermediate” stage exists (the stage between a normal mole and melanoma). It turns out that such a stage does exist, and examining the genetic mutations in a mole can determine whether it may soon progress into cancer.